The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications
Open accessAbstract
Diabetic retinopathy (DR), with increasing incidence, is the major cause of vision loss and blindness worldwide in working-age adults. Diabetic macular edema (DME) remains the main cause of vision impairment in diabetic patients, with its pathogenesis still not completely elucidated. Vascular endothelial growth factor (VEGF) plays a pivotal role in the pathogenesis of DR and DME. Currently, intravitreal injection of anti-VEGF agents remains as the first-line therapy in DME treatment due to the superior anatomic and functional outcomes. However, some patients do not respond satisfactorily to anti-VEGF injections. More than 30% patients still exist with persistent DME even after regular intravitreal injection for at least 4 injections within 24 weeks, suggesting other pathogenic factors, beyond VEGF, might contribute to the pathogenesis of DME. Recent advances showed nearly all the retinal cells are involved in DR and DME, including breakdown of blood-retinal barrier (BRB), drainage dysfunction of Müller glia and retinal pigment epithelium (RPE), involvement of inflammation, oxidative stress, and neurodegeneration, all complicating the pathogenesis of DME. The profound understanding of the changes in proteomics and metabolomics helps improve the elucidation of the pathogenesis of DR and DME and leads to the identification of novel targets, biomarkers and potential therapeutic strategies for DME treatment. The present review aimed to summarize the current understanding of DME, the involved molecular mechanisms, and the changes in proteomics and metabolomics, thus to propose the potential therapeutic recommendations for personalized treatment of DME.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–210 of 210
Crider, J. Y., Yorio, T., Sharif, N. A., & Griffin, B. W. (1997) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1997.13.337 · Cited by 25
Grauslund, J., Frydkjær-Olsen, U., Pető, T., Fernández‐Carneado, J., Ponsati, B., Hernández, C., Cunha-Vaz, J. G., Simó, R., & EUROCONDOR, F. T. (2019) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-26487 · Cited by 25
Erythrocyte membrane fluidity as a marker of diabetic retinopathy in type 1 diabetes mellitus
Bianchetti, G., Viti, L., Scupola, A., Leo, M. A. S. D., Tartaglione, L., Flex, A., Spirito, M. D., Pitocco, D., & Maulucci, G. (2020) · European Journal of Clinical Investigation · doi:10.1111/eci.13455 · Cited by 25
Real-life outcomes of subthreshold laser therapy for diabetic macular edema
Passos, R. M., Malerbi, F. K., Rocha, M., Maia, M., & Farah, M. E. (2021) · International Journal of Retina and Vitreous · doi:10.1186/s40942-020-00268-3 · Cited by 25
Bianchetti, G., Ciccarone, F., Ciriolo, M. R., Spirito, M. D., Pani, G., & Maulucci, G. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.12.048 · Cited by 18
Bianchetti, G., Clementi, M. E., Sampaolese, B., Serantoni, C., Abeltino, A., Spirito, M. D., Sasson, S., & Maulucci, G. (2022) · Antioxidants · doi:10.3390/antiox11061072 · Cited by 17
Intraocular Pharmacokinetics of 10-fold Intravitreal Ranibizumab Injection Dose in Rabbits
Kim, H. M., Park, Y. J., Lee, S., Son, J. Y., Hong, H. K., Ham, M. H., Jin, X., Chung, J., Park, K. H., Park, K. D., et al. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.4.7 · Cited by 13
Tékus, V., Horváth, Á. I., Csekő, K., Szabadfi, K., Kovács-Valasek, A., Dányádi, B., Deres, L., Halmosi, R., Sághy, É., Varga, Z. V., et al. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111105 · Cited by 12
Valent, D. J., Wong, W. T., Chew, E. Y., & Cukras, C. A. (2018) · Translational Vision Science & Technology · doi:10.1167/tvst.7.6.24 · Cited by 10
Han, R., Gong, R., Liu, W., & Xu, G. (2022) · Current Eye Research · doi:10.1080/02713683.2022.2068181 · Cited by 9
Metadata
- Authors
- Zhang, J., Zhang, J., Zhang, C., Zhang, J., Gu, L., Luo, D., & Qiu, Q.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2022-10-25
- Volume
- 11
- Issue
- 21
- Pages
- 3362
- ISSN
- 2073-4409 (ISSN-L)
- OpenAlex
- W4307370122
- Cited by
- 300
- References
- 210
- FWCI
- 38.36
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.